AzTrials
AzTrials

PreDiabetesTRIMNCT03527368

The Time-Restricted Intake of Meals Study

A study testing Time-restricted feeding and Usual feeding pattern in people with PreDiabetes and Obesity, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

TRIM is a randomized, controlled feeding study to evaluate if eating earlier in the day vs. later in the day impacts weight and glucose homeostasis. Read more about this study

Who is it for?
Ages 21 to 69 yearsHealthy volunteers can take part
Conditions the study is for
PreDiabetes, Obesity
What is being tested?
Time-restricted feeding and Usual feeding pattern
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
24 Sep 2018to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 69 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9%
  • Class I-III obesity (BMI 30-50 kg/m2)
  • If on medications for hypertension, stable regimen for at least past 6 months
  • Willingness to adjust timing of feeding
  • Willingness and ability to eat study diet and nothing else during run-in and intervention
  • Willingness to complete measurement procedures

Who cannot join

  • Moderate to severe obstructive sleep apnea
  • Shift work;
  • Other sleep/circadian disorders: e.g., circadian phase delay or phase advance; restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night
  • Routinely ate within compressed time window in the past year (e.g., routinely eats all food within an 10-hour or narrower window, follows an intermittent fasting protocol)
  • Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34)
  • Use of glucose-lowering medications, weight loss medications, medications for sleep disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids, diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic drugs and antiretroviral therapy
Show all 21Show fewer
  • Body weight >400 pounds (limitation of facility scales)
  • >1 drink per day of alcohol
  • Active substance use disorder or significant psychiatric/psychologic disorder that would interfere with participation
  • Significant food allergies, preferences, intolerances, or dietary supplements that would interfere with diet adherence
  • Weight loss or gain of ≥5% during past 6 months
  • Pregnant, planning to become pregnant, or breastfeeding
  • Planning to start a weight loss program
  • Planning to leave the area prior to end of study
  • Current participation in another clinical trial
  • Cancer diagnosis requiring active treatment in past two years or planned treatment (with exception of localized non-melanoma skin cancer)
  • Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal surgery involving bowel resection
  • Myocardial infarction or stroke in past 6 months
  • Prior bariatric surgery
  • Any serious illness that would interfere with participation
  • Other conditions or situations at the discretion of the PI

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Johns Hopkins ProHealth

    Baltimore, Maryland, 21207

Other trials in United States

About this study

Official title: The Time-Restricted Intake of Meals Study: A Randomized, Controlled Feeding Study

TRIM is a randomized, controlled feeding study to evaluate if eating earlier in the day vs. later in the day impacts weight and glucose homeostasis.

Conditions
PreDiabetes, Obesity
Being tested
Time-restricted feeding, Usual feeding pattern
Medical subject headings
Prediabetic State, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Time-restricted feedingBehavioural

    Participants consume food earlier in the day

  • Usual feeding patternBehavioural

    Participants consume food later in the day

Study groups in NCT03527368
Study groupRoleWhat they receive
Time-restricted feedingExperimentalNot described
Receives: Behavioral: Time-restricted feeding
Usual feeding patternOtherComparison
Receives: Behavioral: Usual feeding pattern

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight Change

    Weight change will be measured in kg

    Measured: 12 weeks

Secondary outcomes (4)
  1. Fasting glucose

    Change in fasting glucose

    Measured: 12 weeks

  2. HOMA-IR

    Change in HOMA-IR

    Measured: 12 weeks

  3. AUC glucose

    Area-under-the-curve for glucose on OGTT

    Measured: 12 weeks

  4. Glycated albumin

    Glycated albumin

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2018
  2. Study start24 Sep 2018
  3. Primary completion23 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03527368
Sponsor's protocol ID
IRB00155640
Other IDs
17SFRN33590069
Acronym
TRIM
Status last verified
May 2021
First submitted
4 May 2018
Last updated
17 May 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Duan D, Carnell S, Pilla SJ, Chung ST, Clark JM, Maruthur NM. Time-Restricted Eating on Appetite and Inflammation in Adults With Obesity and Prediabetes: A Randomized Feeding Study. Obesity (Silver Spring). 2026 Jul 27. doi: 10.1002/oby.70270. Online ahead of print.

    PubMed 42508996
  • Duan D, Pham LV, Jun JC, Turkson-Ocran RA, Pilla SJ, Clark JM, Maruthur NM. Effects of time-restricted eating on actigraphy-derived sleep parameters: post hoc analysis of a randomized, isocaloric feeding study. Sleep. 2025 Sep 9;48(9):zsaf089. doi: 10.1093/sleep/zsaf089.

    PubMed 40241264
  • Maruthur NM, Pilla SJ, White K, Wu B, Maw MTT, Duan D, Turkson-Ocran RA, Zhao D, Charleston J, Peterson CM, Dougherty RJ, Schrack JA, Appel LJ, Guallar E, Clark JM. Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity : A Randomized Controlled Trial. Ann Intern Med. 2024 May;177(5):549-558. doi: 10.7326/M23-3132. Epub 2024 Apr 19.

    PubMed 38639542

Questions about this trial

What is this clinical trial studying?

A study testing Time-restricted feeding and Usual feeding pattern in people with PreDiabetes and Obesity, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight Change (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03527368, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2021; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in